...
首页> 外文期刊>European journal of gynaecological oncology >Analysis of protein profiles in human epithelial ovarian cancer tissues by proteomic technology.
【24h】

Analysis of protein profiles in human epithelial ovarian cancer tissues by proteomic technology.

机译:通过蛋白质组学技术分析人上皮性卵巢癌组织中的蛋白质谱。

获取原文
获取原文并翻译 | 示例

摘要

BACKGROUND: Screening in ovarian cancer is progressively finding out candidate genes and proteins which may work as screening biomarkers and play a role in tumor progression. We examined the protein expression patterns of ovarian cancer tissues using two-dimensional gel electrophoresis (2-DE) and matrix-assisted laser desorption/ionization-time of fight mass spectrometry (MALDI-TOF MS). METHODS: Tissues from 36 ovarian cancers and 20 normal ovaries were examined by 2-DE. The images of silver stained gels were analyzed by ImageMaster 2D Elite. The peptide mixtures, after in-gel digestion, were determined by MALDI-TOF MS for fingerprinting. The de-isotope tryptic peptide profiles were matched by using the Mascot search engine based on the entire NCBI and Swiss-Prot protein databases. Western/dot blots were then applied to verify the findings. RESULTS: In ovarian cancer, 12 proteins that showed differential expressions were identified unequivocally. Among these proteins, five proteins (galectin-1, cathepsin B, ubiquitin carboxy-terminal hydrolase L1, HLA class II antigen DRB1-11 and heat shock protein 27) were up-regulated and seven proteins (cellular retinol-binding protein, transthyretin, SH3 binding glutamic-rich-like protein, tubulin-specific chaperone A, DJ-1, gamma-actin and tropomyosin 4) were down-regulated. CONCLUSION: The present study is the first to report the up-regulation of ubiquitin carboxy-terminal hydrolase L1 and the down-regulation of SH3 binding glutamic-rich-like protein, tubulin-specific chaperone A, and tropomyosin 4 in human ovarian cancer tissues. Further cloning and functional analysis of these salient proteins will provide more information on their pathophysiologic roles in ovarian cancer.
机译:背景:卵巢癌的筛查正在逐步发现候选基因和蛋白质,这些基因和蛋白质可以作为筛查生物标志物并在肿瘤进展中发挥作用。我们使用二维凝胶电泳(2-DE)和基质辅助激光解吸/战斗时间质谱(MALDI-TOF MS)检查了卵巢癌组织的蛋白质表达模式。方法:通过2-DE检查来自36个卵巢癌和20个正常卵巢的组织。银染凝胶的图像由ImageMaster 2D Elite分析。凝胶内消化后,通过MALDI-TOF MS确定肽混合物的指纹。通过使用Mascot搜索引擎,基于整个NCBI和Swiss-Prot蛋白质数据库,对异同位素胰蛋白酶肽谱进行了匹配。然后应用蛋白质印迹/斑点印迹来验证发现。结果:在卵巢癌中,明确鉴定了12种显示差异表达的蛋白质。在这些蛋白质中,有5种蛋白质(半乳凝素-1,组织蛋白酶B,泛素羧基末端水解酶L1,HLA II类抗原DRB1-11和热休克蛋白27)上调,还有7种蛋白质(细胞视黄醇结合蛋白,运甲状腺素蛋白, SH3结合富含谷氨酸样蛋白,微管蛋白特异性伴侣蛋白A,DJ-1,γ-肌动蛋白和原肌球蛋白4)下调。结论:本研究是第一个报道人卵巢癌组织中泛素羧基末端水解酶L1上调和SH3结合谷氨酸丰富样蛋白,微管蛋白特异性伴侣A和原肌球蛋白4的下调。 。这些突出蛋白的进一步克隆和功能分析将提供有关其在卵巢癌中的病理生理作用的更多信息。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号